UG Research - Institute of Pharmacy
Institute of Management, Nirma University - Logo

UG Research

UG Research

Nirma University serves as a foundation for students’ overall development. In line with the University Research Policy, the Institute of Pharmacy also envisions basic, applied, and socially relevant research apart from conducive learning. Institute of Pharmacy, Nirma University, has established an Undergraduate Research Council to encourage the interest of UG students in research-related activities. These activities include providing guidance for innovative ideas, engaging students in practical and real-life problem solving, and nurturing their creativity. This initiative aims to pique students’ interest in research by providing mentorship and pursuing multi-disciplinary research in pharmaceutical sciences.

Objectives:

  1. To promote UG research and related activities.
  2. To help UG students in understanding the importance of research.
  3. To facilitate students with eminent mentors for discussions and understanding the research problem and writing scientific problem definition.
  4. To involve students in the research domain of their interest, training through PG/Ph.D. counterpart or handholding by doctoral students.
  5. To allocate a faculty and senior student as mentor to support interdisciplinary groups and developing networks among peer groups.
  6. To nurture the ideas through financial support under Idea Lab.
  7. To promote student exchange with reputed organizations of India and abroad.

UGSRC Publication during Academic Year 2025-26:

  1. Neha R. Raghani, Saima, Devarsh Sutaria, Prinsa R. Nagar, and Tejas M. Dhameliya Updates on Ionic Liquids Catalyzed Synthetic Endeavours for Nitrogen and/or Oxygen Containing Heterocyclic Scaffolds Reported in 2023. Current Organic Chemistry 30, 1296-1314, 2026 June, IF = 2.5, Q2, Devarsh Sutaria (21BPH025)
  2. Aliasgar Baldiwala, Azim M Baldiwala, Manan Patel, Pritkumar Amrutiya, Gopal Natesan, and Udit Chaube Artificial intelligence for next-generation anxiolytic drug discovery: current trends, challenges, and future perspectives. Chemical Papers, 80, 3335–3358 2026 January, IF = 2.5, Q2 Aliasgar Baldiwala, Manan Patel, Pritkumar Amrutiya (22pd001, 22pd014, 22pd022)
  3. Shaival Bhatt, Bushra Patel, Ashna Patel, Sakshi Daftari, Hardik Bhatt, Sarat K. Dalai, Vivek K. Vyas Rational design of novel 2-aminopyrido[3,4-d]pyrimidin-4-one derivatives as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors using 3D QSAR, docking, and molecular dynamics simulation approaches. Letters in Drug Design & Discovery 23 (1), 100371, 2026 January IF = 1.6, Q3, Ashna Patel, Bushra Patel and Sakshi Daftari (21bph011, 21bph020 & 21bph082)
  4. Ruchi Yadav, Nidhi Nambiar, Manushi Shah, Bhumika D. Patel Exploring the therapeutic potential of Momordica charantia in targeting protein kinase C delta (PRKCD) for type 2 diabetes mellitus: insights from network pharmacology, molecular docking, and molecular dynamics simulations. In Silico Pharmacology 12(2) 99 2025 July IF = 0 (Manushi Shah, Nidhi Nambiar 20bph065, 20BPH069)

UGRC Publication during Academic Year 2024-25:

  1. Nishi Shah (20BPH070), Nidhi Nambiar (20BPH069), Om Gajera (20BPH071), Shital Panchal. A Systematic Review on Neuromarketing in Pharmaceutical Industries. 2024, 11(2), Nirma Journal of Pharmaceutical Sciences. 57-78, https://doi.org/10.5281/ (IF: NA)
  2. Tulsian Kartik (20BPH053), Dhinal Thakker (20BPH023) and Vivek K. Vyas. “Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review.” International journal of biological macromolecules (2025): 141364 (IF: 7.7)
  3. Savaliya Vidhisha N. (20BPH109), Priyansh Rastogi (20BPH078), Prit D. Savaliya (20BPH077), Punam Salaria, Amarendar Reddy M, Vivek K. Vyas, Gopal Natesan, and Tejas M. Dhameliya. “Investigations Through in Silico Molecular Modelling Against Falcipain‐2 in Search of Potent Anti‐Malarial Agents.” ChemistrySelect 10, no. 19 (2025): e202405449 (IF: 1.9)
  4. Shah Deep (19BPH024), Drashti Gajjar (19BPH040), Drishti Kapadia (19BPH042), Varun Danayak (19BPH110), Ritu Soni, Yash Patel, Mayur Patel and Jigna Samir Shah. “Prevalence of Patient Awareness and Compliance in T2D Patients in the Urban Ahmedabad Region: A Retrospective and Prospective Study.” Clinical Diabetology 13, no. 4 (2024): 200-207. (IF: 0.7)
  5. Thaker Aanal (22BPH001), Shrusti Patel (22BPH097), Rajdeep Dey, Suman Shaw, Hardik Bhatt, Bhumika Patel, and Udit Chaube. “Advancements in mTOR Inhibitors for Non-Small-Cell Lung Cancer: Mechanisms, Efficacy, and Future Perspectives.” Synlett (2025). (IF: 1.7)

UGRC Activities during Academic Year 2023-24:

  1. Expert Lectures
  2. Events
  3. Student Achievements